ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
84 announcements with these filters
Neogen Chemicals has paid Rs.1.69 Crore in interest for its non-convertible debentures (NCDs) for August 2026. This periodic payment complies with SEBI listing regulations.
Neogen Chemicals has received shareholder approval for raising funds up to Rs. 600 Crore. The company obtained this in-principle authorization for future capital issuance.
Neogen Chemicals concluded its 37th Annual General Meeting on August 21, 2026. Proceedings included financial adoption, dividend declaration, and authorization for future fund-raising.
SBI Mutual Fund sold 2,11,931 shares of Neogen Chemicals Limited via market sale. Its stake decreased from 6.80% to 6.02%.
Neogen Chemicals has fixed August 16, 2026, as the record date for interest payments on its listed NCDs (ISIN INE136S07013).
Neogen reported robust Q1 FY27 results with 34% revenue growth and 53% EBITDA growth. Strategy pivots toward battery materials and organo-lithium, supported by a ₹600 crore QIP for de-leveraging.
Neogen Chemicals has paid Rs. 1.65 Crore as step-up interest on its listed NCDs. This filing provides the mandatory Regulation 57 interest payment intimation.
Neogen Chemicals Ltd filed its Business Responsibility and Sustainability Report (BRSR) and Assurance Report for the financial year 2025-26.
Neogen Chemicals Ltd issued the notice for its 37th Annual General Meeting scheduled for August 21, 2026. The meeting includes enabling resolutions for future capital raising.
Neogen Chemicals submitted its Integrated Annual Report for F.Y. 2025-26 and scheduled its 37th Annual General Meeting for August 21, 2026.
Neogen Chemicals confirmed the payment of interest on its non-convertible debentures. This regulatory filing satisfies standard disclosure requirements for interest payments.
Neogen reported robust Q1 FY27 results with consolidated revenue growing 34% and PAT up 67% YoY. Growth was driven by the Organolithium portfolio and the ramp-up of Neogen Ionics.
Neogen Chemicals reported Q1 FY27 results with Rs. 250 crore revenue. The Board also approved a fund-raise of up to Rs. 600 crore via QIP.
Neogen Chemicals received board approval to raise up to ₹600 Crore via issuance of equity or other eligible securities. The company will determine the specific fundraising mode later.
Neogen Chemicals Limited has recommended a final dividend of ₹0.10 per equity share for the financial year. The record date is set for 13-August-2026.
Neogen Chemicals Limited has appointed CNK & Associates LLP as its new Internal Auditor, effective July 24, 2026, for a term of 12 months.
Neogen Chemicals filed its quarterly Security Cover Certificate for NCDs as of June 30, 2026, confirming compliance with SEBI Regulations regarding debt security maintenance.
Neogen Chemicals Ltd reported revenue from operations of ₹250.3 Cr (+34.1% YoY) and net profit of ₹17.1 Cr (+66.0% YoY) for Q1 FY27.
Neogen Chemicals Ltd's MD, Dr. Harin Kanani, has pledged 33,38,250 equity shares with Axis Trustee Services Limited. This pledge creates an encumbrance on promoter holdings.
Neogen Chemicals Ltd increased the coupon rate on its ₹200 Crore NCDs from 10.50% to 11.00% following a credit rating downgrade.
Neogen Chemicals Ltd will hold a board meeting on July 24, 2026, to approve the Q1 FY27 financial results and discuss a potential fundraising proposal.
CRISIL Ratings downgraded credit ratings for Neogen Chemicals Limited and its subsidiary, Neogen Ionics Limited, citing project and insurance claim delays.
Neogen Chemicals received a Rs. 15 Crore insurance payment for its Dahej facility fire. Total claims received reach Rs. 155 Crore against recognized losses.
Neogen Chemicals disclosed the record date and payment date for interest on its listed NCDs. Interest will be paid on July 31, 2026.
Neogen Chemicals paid Rs.1.55 Cr interest on its NCDs for June 2026. The payment amounts to approximately ₹10.56 Crore.
Neogen Chemicals fixed June 15, 2026, as the record date for interest payments on its NCDs. Payment is scheduled for June 30, 2026, ensuring regulatory compliance.
Axis Mutual Fund sold a 1.46% stake in Neogen Chemicals via open market transactions. Its holding reduced to 4.04%, reflecting institutional profit-booking or portfolio rebalancing.
Neogen Chemicals paid ₹1.61 Crore in monthly interest for its listed NCDs on May 28, 2026. This confirms timely debt service compliance for investors.
Neogen Chemicals submitted its Annual Secretarial Compliance Report for FY2026. The document details historical non-compliance regarding director re-appointments and confirms that all associated exchange fines were paid.
Neogen reported Q4 FY26 revenue of ₹247 crore (+22% YoY) and EBITDA of ₹44 crore (+21% YoY). The company is transitioning towards a battery materials-led portfolio with massive capex in Pakhajan and Dahej.